PharmacoepidemiologyRoutledge, 19 dic 2018 - 360 páginas This volume is comprised of papers presented at the Third International Conference on Pharmacoepidemiology, held September 9-11, 1987, in Minneapolis, Minnesota. The book is divided into four sections, which reflect the four themes of the conference: Social Impact of Pharmacoepidemiology; Drug Epidemiology and the Law; Drug Surveillance; and Drugs, Populations, and Outcomes: Specific Studies. The collection of papers discusses the social and legal impact of epidemiology, the system of checks and balances that is necessary for the field, the importance of core support for researchers, and the goal of an enlightened and informed public, including the media, consumer advocates, and the courts. Contributing authors offer perspectives from academia, practice, government, industry and the law. Numerous tables and figures are included to illustrate many of the papers within the text. This book offers substantial reading for epidemiologists and individuals interested in the field of pharmacoepidemiology. |
Índice
Section TwoDrug Epidemiology and the Law | 51 |
Section ThreeDrug Surveillance | 117 |
Specific Studies | 225 |
Appendix | 353 |
355 | |
Otras ediciones - Ver todo
Términos y frases comunes
acyclovir adverse drug reactions adverse events adverse experiences adverse reaction reporting aminoglycoside analysis antibiotics antidepressants anxiolytics assessment associated Bendectin birth defects cancer causation cimetidine clinical trials court creatinine Creutzfeldt-Jakob disease data base diagnoses diclofenac differences disease DMARD dose Drug Administration Drug Surveillance effect epidemiologic epidemiologic studies estimated evaluation evidence expert follow-up Food and Drug Francis Group http://taylorandfrancis.com frequency gastrointestinal history of convulsions hospital ibuprofen included increase infection intensive care unit Judge Shoob length of stay males monitoring nephrotoxicity nonsteroidal antiinflammatory drugs NSAIDs outcome overdose peptic ulcer pharmaceutical pharmacoepidemiology physicians piroxicam plaintiffs population postmarketing surveillance potential prescribed prescription problem psychotropic drug psychotropic medications records regression regulatory relative risk reporting rates Retrovir scientific seizures serum specific spermicides spontaneous reports statistically significant sulindac symptoms Table Taylor & Francis testimony theophylline therapy tion tobramycin toxicity UGI bleeding upset vaccine variables versus